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mode chip designed in 130 nm CMOS technology [1]. We 
present results of a PET-ToF demonstrator scanner based on 
this ASIC and featuring a highly integrated readout and DAQ 
system. 
The Detector Module is composed of 8 matrices of 4x4 LYSO 
scintillating crystals, each with a size of 3.1 x 3.1 x 15 mm3. 
These matrices are optically coupled to 8 arrays of 
Hamamatsu TSV-MPPCs. The crystal matrices and associated 
MPPCs plug directly in the Frontend Boards forming a 
compact detecting unit with active area 59x29 mm2. The 
present results were obtained with a partially assembled ring 
(16 Modules) corresponding to 2048 SiPM readout channels. 
The Frontend board integrates two ASICs allowing the 
readout and digitization of 128 MPPC pixels. On-chip TDCs 
produce two time measurements allowing the determination 
of the event time and of the time-over-threshold. A 
Concentrator board reads the data from eight Frontend 
boards (1024 channels) and transmits assembled data frames 
through a serial link to the PCIe based DAQ board in the data 
acquisition PC.  
At present the PET-ToF demonstrator is fully assembled and 
in operation (Figure 1). We will report on the detector 
performance, including energy resolution, spatial resolution, 
time resolution and rate performance of the system. Images 
with phantoms will also be presented. 
 
 
Figure 1 - Flood histogram of the full scanner obtained 
with a Na22 point source. 
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The cell membrane not only functions as a physical barrier 
between the intracellular and extracellular space, it harbors 
critical components involved in receptor-ligand interactions, 
signal transduction and drug uptake. Targeting the cell 
membrane represents a novel strategy to improve anti-
cancer therapy. Our work focuses on two different 
approaches. The first involves lipid rafts. These are dynamic, 
cholesterol/sphingolipid-enriched microdomains within 
biological membranes, and play a crucial role in the 
induction of (apoptotic) cell death by radiation, pro-
apoptotic receptor agonists and synthetic alkyl-
phospholipids. 
The second approach addresses insufficient drug delivery into 
tumor cells, which represents a major limitation of cytostatic 
therapy. We found that co-formulation and co-administration 
of liposome-encapsulated chemotherapy and synthetic short-
chain sphingolipids (SCS) improves drug availability by 
enhancing intracellular drug uptake. Specific biophysical 
requirements of both the SCS (chain length and polarity) and 
chemotherapeutic agent (amphiphilicity) determine the 
optimal conditions for improved drug delivery. Doxorubicine 
and mitoxantrone are two frequently prescribed 
chemotherapeutic agents that benefit from this cell 
membrane-targeting approach. In vitro and in vivo studies 
demonstrate higher drug efficacy and/or lower toxicity in 
relevant tumor model systems. Mechanistic analyses 
demonstrate that SCS preferentially insert into tumor cell 
membranes enhancing the intrinsic capacity to translocate 
amphiphilic drugs.  
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Purpose: Modern radiotherapy is based on using small 
radiation fields and their segments. For clinical use they 
need to be verified by measurement. But measurement of 
small radiosurgery fields is very problematic task because of 
dosimetry challenges, such as loss of charged particle 
equilibrium, accurate positioning of detector and its small 
size. Purpose of this study is to assess new synthetic single 
crystal MicroDiamond PTW 60019 detector. Its dosimetry 
characteristics from the manufacturer and especially small 
size of its sensitive volume (0.004 mm3) make the detector 
promising tool for this task. 
Materials and Method: In this study basic dosimetry 
characteristics of MicroDiamond detector were verified in 
clinical linear accelerator photon and electron beams. 
Measurements involved short time stability and detector 
response dependence on dose rate, beam energy, 
temperature and angular dependence. In addition, 
measurement of relative output factors for Leksell Gamma 
Knife Perfexion was performed in order to test dosimeter 
performance for small fields. Collimator sizes 4 mm, 8 mm 
and 16 mm were used. Results obtained by this detector 
were compared with ELEKTA reference values and 
independent Monte Carlo Geant4 simulation. 
Results: Stabilization of detector response was always 
performed before starting measurement. For this purpose 40 
minutes irradiation in reference conditions was necessary 
(corresponding delivered dose was about 100 Gy). After this 
time the response was relatively stable with difference 
between maximum and minimum value 0.25% and standard 
deviation of all measurements 0.07% within an hour 
(normalized for this and all subsequent measurements to 
mean value of response). Dose rate dependence was 
measured for 6 different dose rates. Difference between 
maximum and minimum value was 0.24%. Energy dependence 
of detector was performed for 2 photon energies (6 and 18 
MV) and 5 electron energies (6-20 MeV). Difference between 
maximum and minimum photon beam values was 0.12%, for 
electron beams this difference was 4.54% with standard 
deviation of response values 1.62%. Results for temperature 
and angular dependence are not finalized yet. Finally, results 
of comparative measurement for relative output factors of 
the Leksell Gamma Knife for 4 and 8 mm collimators were 
0.831 and 0.900, respectively. These values are in a good 
agreement with vendor values (0.814 and 0.900) and Monte 
Carlo simulation. 
Conclusion: New MicroDiamond PTW 60019 detector appears 
to be a promising detector for relative output factor 
measurements in small radiosurgery fields. Verified 
dosimetric properties of the detector are in limits set by 
manufacturer. However, relatively long pre-irradiation 
process is necessary prior to measurement before the 
detector can produce reliable data. Further measurements 
will follow. This work was supported by CTU grant no. 
SGS15/217/OHK4/3T/14. 
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Development of clinical treatment protocols for radiation 
therapy is dependent on the availability of information on 
the biological efficacy of radiation doses. In order to gain 
robust data, multiple cell irradiation experiments must be 
performed at different dose points, using a range of cell 
lines. Therefore, it is important to be able to verify the 
biological effects of complex dose distributions in 
homeomorphic phantoms, alongside 
measurements of physical dose. One of the ENTERVISION 
projects focuses on the development of a biological 
dosimetric phantom. Firstly, the phantom and desired set-ups 
were evaluated then its suitability for radiobiology studies 
were accessed during a set of cell irradiations. Status: The 
phantom was irradiated mimicking the patients′ pathway 
starting with the CT scan, followed by treatment planning 
and being irradiated. For the irradiation, an uniform dose 
distribution was delivered with a proton beam and the 
process was repeated using a carbon ion beam. The dose was 
measured from pinpoint ionisation chambers readings and the 
uniformity was assessed with radiochromic films. The 
experimental results were compared with the TPS and Monte 
Carlo calculations. Using MC simulations it was also 
investigated how the simulation of a more detailed geometry 
would affect the obtained results. From the radiobiology 
studies the cell survival by analyzing its proliferation was 
studied. Results: The calculated mean deviation was below 
2% for both beams used. This brings the result within the 
acceptance threshold as desired by CNAO QA procedures. 
Conclusion: The experimental results obtained showed good 
agreement with both TPS and Monte Carlo simulations. And 
the radiobiological results showed the possibility of multi-
variable analysis (LET and Dose) that is available to be done 
with the ENTERVISION Phantom. 
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Introduction: The increased availability of PET-CT devices in 
addition to the interchange of people and technology 
between nuclear medicine and radiology explains the 
increased use of CT techniques like enhanced contrast CT in 
nuclear medicine. The benefits of the use of contrast agents, 
especially in terms of the increased accuracy, for enhancing 
different image modalities are understood and well discussed 
in the literature. On the other hand, in terms of evaluating 
the different side effects from the use of these contrast 
agents only the visible and short-term reactions have been 
discussed. In respect to studying for a possible increase in 
dose exposure from the interaction of the 
radiopharmaceutical radiation with the contrast agent in a 
contrast enhanced PET-CT study and its effect in the patient 
radiation exposure is yet to be investigated.  
Materials and Methods: This study is aimed to investigate the 
dose deposition differences with respect to the nuclear 
medicine isotope radiation interaction with the high density 
and atomic number of the contrast agent due to increased 
absorption and scatter of the internal radiation in the 
patients’ tissue. This has been performed with the use of 
Monte Carlo simulations of 10 patient studies where contrast 
agent had been used.   
Results: Preliminary results show an increase in the dose 
deposition in the regions enhanced by contrast and its 
surroundings.   
Conclusion: Further quantification of this increased dose 
deposition in different organs at risk and its estimated effect 
will be presented.   
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Purpose: In the last two decades, particle therapy is slowly 
spreading from complementary programs of research 
institutions to dedicated healthcare facilities. Together with 
this evolution, particle therapy is refocusing from passive 
modes to the active pencil beam scanning mode (PBS). 
Higher degree of freedom, in sense of treatment conformity 
in PBS, is followed by more extensive demands in patient 
geometry determination. PTC Czech in Prague launched in 
December 2012 in PBS and it is the only mode of proton beam 
delivery currently used for patient treatment. The use of PBS 
technique raised new challenges such as plan robustness 
during the treatment course and mitigation of breathing 
motion influence on PBS treatment field delivery. The 
purpose of this poster is to demonstrate some of motion 
management studies conducted in the course of preparation 
for lung/breast lesions treatment. 
Materials and Methods: A study with “MartiXX phantom” 
simulating breathing movement was conducted in order to 
examine the use of the repainting technique combined with 
respiratory gating. The goal was to evaluate the benefit of 
this combination for dose distribution delivery robustness 
against prolonged treatment time in the case of repainting 
itself. In another study, four Hodgkin’s lymphoma patients, 
where respiratory gating system (Dyn’R) was applied, were 
examined. The inter-fractional movement of diaphragm on 
their setup X-ray images was evaluated. For the evaluation a 
script for edge detection using ITKsnap library was created. 
The error of this method was 1 mm. 
Results: The evaluation of the “MartiXX phantom” 
experiment demonstrated significant mitigation of breathing 
motion when respiratory gating was applied. In this case, the 
treatment time was increased by 98 %. The use of gating 
combined with 5 times repainting demonstrated only mild 
improvement in movement mitigation compared to gating 
only case at cost of 233 % time increase. The degree of the 
dose distribution delivery improvement was evaluated 
through gamma analysis of dose planes acquired with MartiXX 
detector for dynamic and static case. 
The evaluation of the diaphragm movement showed for 3 
patients the difference trespassing the 5 mm threshold in 2-3 
setups out of 7-11 of total, while in the case of the fourth 
patient all deviations were beneath 4 mm. 
Conclusions: The selected studies for this poster suggest a 
strong benefit of respiratory gating. Additional mitigation 
technique like repainting might improve the outcome of dose 
delivery, but at a high treatment time cost. Nevertheless, 
the choice of the mitigation strategy should be always 
verified with a PET-QA in order to adopt the strategy if 
needed. Further, the evaluation of diaphragm position 
reproducibility gives some encouraging results although there 
are some papers [6] claiming low correlation of tumor lesion 
and diaphragm position. 
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